Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$747M |
| 2 |
AstraZeneca
AZN
|
+$546M |
| 3 |
Meta Platforms (Facebook)
META
|
+$526M |
| 4 |
Microsoft
MSFT
|
+$521M |
| 5 |
HONA
Honeywell Aerospace
HONA
|
+$386M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$494M |
| 2 |
SNDK
Sandisk
SNDK
|
+$482M |
| 3 |
Honeywell
HON
|
+$365M |
| 4 |
CTRA
Coterra Energy
CTRA
|
+$362M |
| 5 |
EA
Electronic Arts
EA
|
+$345M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.11% |
| 2 | Financials | 17.17% |
| 3 | Industrials | 12.92% |
| 4 | Consumer Discretionary | 9.96% |
| 5 | Healthcare | 9.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2826
ImmunityBio
IBRX
$8.63B
| $1.2M | ﹤0.01% |
136,632
+26,623
| +24% | +$202K |
|
|
CPAC
2827
Cementos Pacasmayo
CPAC
$1.08B
| $1.19M | ﹤0.01% |
99,419
-4,658
| -4% | -$50.5K |
|
2828
Compass Therapeutics
CMPX
$333M
| $1.18M | ﹤0.01% |
541,178
+101,394
| +23% | +$299K |
|
2829
CNA Financial
CNA
$13.1B
| $1.18M | ﹤0.01% |
24,314
+161
| +0.7% | +$7.33K |
|
|
VBNK
2830
VersaBank
VBNK
$723M
| $1.18M | ﹤0.01% |
50,912
| – | – |
|
2831
Grab
GRAB
$11.9B
| $1.18M | ﹤0.01% |
312,223
-29,658
| -9% | -$108K |
|
|
AXIA.PRC
2832
DELISTED
AXIA Energia American Depositary Shares Preferred Class C
AXIA.PRC
| $1.17M | ﹤0.01% |
110,852
-219
| -0.2% | -$2.4K |
|
2833
Transact Technologies
TACT
$52.8M
| $1.17M | ﹤0.01% |
199,924
-28,780
| -13% | -$116K |
|
2834
Fossil Group
FOSL
$298M
| $1.16M | ﹤0.01% |
279,980
+116,945
| +72% | +$524K |
|
2835
Global Water Resources
GWRS
$250M
| $1.15M | ﹤0.01% |
159,179
+17,667
| +12% | +$128K |
|
|
LPRO
2836
DELISTED
Open Lending Corp
LPRO
| $1.15M | ﹤0.01% |
370,382
-404,990
| -52% | -$828K |
|
2837
Protalix BioTherapeutics
PLX
$214M
| $1.15M | ﹤0.01% |
493,424
+196,581
| +66% | +$416K |
|
|
TRAX
2838
First Tracks Biotherapeutics
TRAX
$1.37B
| $1.15M | ﹤0.01% |
+57,064
| New | +$1.07M |
|
|
USAS
2839
Americas Gold and Silver
USAS
$1.59B
| $1.14M | ﹤0.01% |
+241,711
| New | +$1.4M |
|
2840
Bridgford Foods
BRID
$54M
| $1.14M | ﹤0.01% |
175,756
+1,042
| +0.6% | +$7.68K |
|
2841
Auburn National Bancorp
AUBN
$92.5M
| $1.13M | ﹤0.01% |
41,973
+126
| +0.3% | +$3.09K |
|
2842
Stratasys
SSYS
$659M
| $1.13M | ﹤0.01% |
132,603
-804
| -0.6% | -$7.04K |
|
2843
Aldeyra Therapeutics
ALDX
$82.6M
| $1.13M | ﹤0.01% |
529,083
-95,087
| -15% | -$163K |
|
2844
Prime Medicine
PRME
$570M
| $1.12M | ﹤0.01% |
304,678
+156
| +0.1% | +$518 |
|
2845
Haverty Furniture Companies Class A
HVT.A
$455M
| $1.12M | ﹤0.01% |
39,987
| – | – |
|
2846
Alto Neuroscience
ANRO
$1.19B
| $1.12M | ﹤0.01% |
42,561
+3,237
| +8% | +$74.8K |
|
2847
Fidelity D&D Bancorp
FDBC
$329M
| $1.12M | ﹤0.01% |
21,747
+2,412
| +12% | +$113K |
|
2848
American Well
AMWL
$233M
| $1.12M | ﹤0.01% |
122,501
+33,505
| +38% | +$250K |
|
2849
TTEC Holdings
TTEC
$62.6M
| $1.1M | ﹤0.01% |
566,831
-115,513
| -17% | -$298K |
|
2850
The GEO Group
GEO
$4.11B
| $1.09M | ﹤0.01% |
37,033
-619
| -2% | -$14K |
|
Similar funds
Dimensional Fund Advisors's Q2 2026 Portfolio in Review
As of Q2 2026, Dimensional Fund Advisors held 3,315 positions worth $552B, up 15% from $481B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Dimensional Fund Advisors's Q2 2026 filing shows 100 new, 1,949 increased, 1,085 reduced and 94 closed positions. Its largest new stake was AstraZeneca: 2,904,886 shares worth $551M. The largest sale was Advanced Micro Devices, an estimated $494M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q2 2026 buy was AstraZeneca: 2,904,886 shares worth $551M.
- Dimensional Fund Advisors added most to Amazon in Q2 2026, an estimated $747M increase.
- Dimensional Fund Advisors's biggest Q2 2026 reduction was Advanced Micro Devices, cutting an estimated $494M.
- Dimensional Fund Advisors fully exited Coterra Energy in Q2 2026, selling an estimated $362M.
- Dimensional Fund Advisors's ten largest holdings make up 17% of its $552B portfolio in Q2 2026.
- Dimensional Fund Advisors opened 100 new positions and closed 94 in Q2 2026.
- Dimensional Fund Advisors's portfolio value rose 15% quarter-over-quarter to $552B.
Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.